OR WAIT null SECS
May 02, 2012
Service providers must focus on delivering a superior customer experience.
April 02, 2012
Recovery audits and other past practices in procurement can improve the bottom line.
March 02, 2012
The evolving bio/pharmaceutical business model poses risk for CMOs.
February 02, 2012
Industry optimism is on the rise for 2012.
January 02, 2012
Some recent private-equity buyouts of CROs show both the upside and downside for investors.
December 02, 2011
A dearth of late-stage candidates could hurt the pharmaceutical services market in the future.
November 02, 2011
Biosimilar manufacturers need better expression systems and analytical tools to compete.
October 02, 2011
CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.
September 02, 2011
The EU debt crisis portends of possible negative repercussions for the dose CMO industry.
August 02, 2011
China rises to the top as a destination for international outsourcing.